Please try another search
Shukra Pharmaceuticals Limited develops, manufactures, markets, and exports various drugs and dosage forms in India and internationally. Its product portfolio includes macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic, and other products, as well as antibiotics comprising penicillin and cephalosporin. The company was formerly known as Relish Pharmaceuticals Limited and changed its name to Shukra Pharmaceuticals Limited in August 2016. Shukra Pharmaceuticals Limited was incorporated in 1993 and is based in Ahmedabad, India.
Name | Age | Since | Title |
---|---|---|---|
Dakshesh Rameshchandra Shah | 51 | 2012 | Chairman & MD |
Payalben Sujay Mehta | 43 | 2012 | Executive Director |
Dhruvin Shah | 27 | 2023 | Additional Executive Director |
Bhoomiben Patel | 26 | 2019 | Non-Executive Independent Director |
Sarjeevan Singh Rathore | 39 | 2023 | Additional Independent Director |
Sanskruti Jayeshbhai Patel | 27 | 2023 | Additional Executive Director |
Sonal Gandhi | 49 | 2023 | Additional Non-Executive Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review